Skip to main content

Early Detection of Cancer using Lasers Demonstrator

Objective

According to the WHO statistics, cancer causes around 7.6 million deaths worldwide each year. Deaths from cancer are projected to rise to 17 million in 2030. Changes in lifestyle and improved prevention and screening policies could prevent up to 40% of all cancer cases.

On 2 December 2003 the Health Ministers of the European Union unanimously adopted a recommendation on cancer screening based on the developments and experience in the Europe Against Cancer program. The Recommendation of the Council of the European Union spells out fundamental principles of best practice in early detection of cancer and invites EU Member States to take common action to implement national cancer screening programs.

Reports from the US state that Oral Cancer is the most expensive to treat. Most oral cancers require costly and disfiguring medical intervention, and even then the five-year survival rate is only 57%. There are 124.000 new cases diagnosed each year. This gives an additional cost to the medical health care system of €6.944B per year.

Historically the death rate associated with this cancer is particularly high not because it is hard to discover or diagnose, but due to the cancer being routinely discovered late in its development. Today, there is still no comprehensive program to opportunistically screen for the disease, and without that; late stage discovery and high mortality rates are most likely to continue.

In a previous Research for SMEs project: (EDOCAL), the SMEs 2M, CST and TG developed a preliminary test system for early cancer detection using state of the art telecom laser technology. This project finished on 31.12.2011 and the results achieved in were in line with the goals set put at the start of the project.

Our objective in this project is to use the results of the research to build and validate the demonstrator in a clinical setting and subsequently to commercialise the first low cost screening tool for early detection of oral cancers.

Field of science

  • /social sciences/sociology/demography/mortality
  • /medical and health sciences/clinical medicine/oncology/cancer
  • /natural sciences/physical sciences/optics/laser physics

Call for proposal

FP7-SME-2013
See other projects for this call

Funding Scheme

CP - Collaborative project (generic)

Coordinator

2M ENGINEERING LIMITED
Address
Sidney Street 80
CT19 6HQ Folkstone
United Kingdom
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 499 280
Administrative Contact
Gillian Mimnagh (Mrs.)

Participants (4)

COMPOUND SEMICONDUCTOR TECHNOLOGIES GLOBAL LIMITED
United Kingdom
EU contribution
€ 209 820
Address
4 Stanley Boulevard Hamilton International Technol Lantyre
G72 0BN Glasgow
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Mary Kane (Mrs.)
TOP-GAN SP ZOO
Poland
EU contribution
€ 91 950
Address
Ul. Sokolowska 29/37
01 142 Warszawa
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Mike Leszczyńsk (Prof.)
UNIVERSITY OF DUNDEE
United Kingdom
EU contribution
€ 252 120,80
Address
Nethergate
DD1 4HN Dundee
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Neil Stewart (Mr.)
FOCE TECHNOLOGY INTERNATIONAL BV
Netherlands
EU contribution
€ 111 829,20
Address
Waldfeuchterbaan 94
6105 BN Maria Hoop
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Marcel Schemmann (Dr.)